Anapharm Bioanalytics Business Development team will attend Nordic Life Science Days in Stockholm from September 8-9 and Biospain in Bilbao from September 30–October 1 to meet biotech and pharma companies.
Published
Signal category
Presence & Recognition
Quote
“Our Business Development team will be at two major European events and we're looking to meet biotech and pharma companies who need a reliable bioanalytical partner.”
— Anapharm Bioanalytics team
Company
Anapharm Bioanalytics
We aim to become a valued partner for your product research, development and registration.
- Industry
- Research Services
- Location
- Barcelona, ES
- Company size
- 79 employees
Anapharm Bioanalytics is a customer-focused bioanalytical CRO specialized in small and large molecule bioanalysis. Led by a team with over 30 years’ experience in method development, validation and sample analysis, we support drug development programs for the pharmaceutical, biotechnological and generic industries worldwide. Equipped with state-of-the-art LC-MS/MS and LBA technology platforms, Anapharm Bioanalytics provides an array of services including PK studies, biomarker testing and immunogenicity assays throughout preclinical and clinical stages. Our global network of partners allows us to provide full-service outsourcing solutions to conduct preclinical, Phase I-IV clinical trials, and bioequivalence studies for international registration. Our clients benefit from a deep scientific expertise combined with a robust quality system. All our activities are compliant with GLP and GCP, having undergone 20+ regulatory inspections by the FDA, several EU Health Authorities and ANVISA (Brazil). Whether your drug candidate is a new chemical entity, a new biologic, a generic or a biosimilar, do not hesitate to contact us at info@anapharmbioanalytics.com.
Founded 2003